TECH - BIO-TECHNE Corp

QQQ $ 419.06 $ -1.89 (-0.45 %)

DIA $ 377.74 $ -6.35 (-1.65 %)

SPY $ 498.24 $ -4.02 (-0.8 %)

TLT $ 87.74 $ -0.19 (-0.22 %)

GLD $ 216.15 $ 0.82 (0.38 %)

Previous Close

$ 63.52

Open

$ 63.02

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 61.89 - $ 63.23

52 Week Range

$ 51.66 - $ 89.59

Volume

984,815

Average Volume

Market Cap

10.17B

Beta (5Y Monthly)

$ 1.05

PE Ratio (TTM)

$ 45.36

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.01)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-07-2024	12-31-2023	10-Q
2	11-07-2023	09-30-2023	10-Q
3	08-23-2023	06-30-2023	10-K
4	05-08-2023	03-31-2023	10-Q
5	02-07-2023	12-31-2022	10-Q
6	11-07-2022	09-30-2022	10-Q
7	08-24-2022	06-30-2022	10-K
8	05-09-2022	03-31-2022	10-Q
9	02-07-2022	12-31-2021	10-Q
10	11-08-2021	09-30-2021	10-Q
11	08-25-2021	06-30-2021	10-K
12	05-07-2021	03-31-2021	10-Q
13	02-08-2021	12-31-2020	10-Q
14	11-09-2020	09-30-2020	10-Q
15	08-26-2020	06-30-2020	10-K
16	05-11-2020	03-31-2020	10-Q
17	02-06-2020	12-31-2019	10-Q
18	11-06-2019	09-30-2019	10-Q
19	08-28-2019	06-30-2019	10-K
20	05-07-2019	03-31-2019	10-Q
21	02-07-2019	12-31-2018	10-Q
22	11-07-2018	09-30-2018	10-Q
23	08-27-2018	06-30-2018	10-K
24	05-09-2018	03-31-2018	10-Q
25	02-08-2018	12-31-2017	10-Q
26	11-09-2017	09-30-2017	10-Q
27	09-07-2017	06-30-2017	10-K
28	05-10-2017	03-31-2017	10-Q
29	02-09-2017	12-31-2016	10-Q
30	11-09-2016	09-30-2016	10-Q
31	08-29-2016	06-30-2016	10-K
32	05-10-2016	03-31-2016	10-Q
33	02-09-2016	12-31-2015	10-Q
34	11-09-2015	09-30-2015	10-Q
35	08-31-2015	06-30-2015	10-K
36	05-11-2015	03-31-2015	10-Q
37	02-09-2015	12-31-2014	10-Q
38	11-10-2014	09-30-2014	10-Q
39	08-29-2014	06-30-2014	10-K
40	05-12-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Navigating 4 Analyst Ratings For Bio-Techne
04/18/2024 16:01:52

Deutsche Bank Maintains Buy on Bio-Techne,...
04/18/2024 12:12:00

Deutsche Bank analyst Justin Bowers maintains Bio-Techne (NASDAQ:TECH) with a Buy and lowers the price target from $85 to $82.

Bio-Techne Surpasses 10K Peer-Reviewed Pub...
04/08/2024 11:11:07

Bio-Techne Corporation (NASDAQ:TECH) today announced that Advanced Cell Diagnostics (ACD), part of Bio-Techne's Spatial Bio...

Bio-Techne And Nikon Instruments Inc. Anno...
03/28/2024 13:09:17

Bio-Techne Corporation (NASDAQ:TECH) is pleased to announce that Lunaphore, part of Bio-Techne's Spatial Biology Division, ...

Bio-Techne Receives European IVDR Certific...
03/22/2024 11:07:43

Bio-Techne: Commitment to Investor Content...
03/07/2024 15:05:08

Bio-Techne: Bolstering Investor Value with...
02/26/2024 15:05:22

By the end of today, February 26, 2024, Bio-Techne (NASDAQ:TECH) is set to deliver a dividend payout of $0.08 per share, equati...

Stephens & Co. Maintains Overweight on Bio...
02/02/2024 17:29:13

Stephens & Co. analyst Jacob Johnson maintains Bio-Techne (NASDAQ:TECH) with a Overweight and lowers the price target fr...

RBC Capital Maintains Sector Perform Ratin...
02/02/2024 17:00:14

RBC Capital Maintains Sector Perform on Bi...
02/02/2024 15:25:59

RBC Capital analyst Conor McNamara maintains Bio-Techne (NASDAQ:TECH) with a Sector Perform and lowers the price target from...

Stifel Downgrades Bio-Techne to Hold, Anno...
02/02/2024 11:41:56

Stifel analyst Daniel Arias downgrades Bio-Techne (NASDAQ:TECH) from Buy to Hold and announces $65 price target.

Bio-Techne Q2 Adj EPS $0.40 Misses $0.41 E...
02/01/2024 11:31:18

Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.40 per share which missed the analyst consensus estimate of $0.41 by...

Earnings Scheduled For February 1, 2024
02/01/2024 10:03:12

Companies Reporting Before The Bell • ING Groep (NYSE:ING) is expected to report earnings for its fourth quarter. • Shell (NY...

Earnings Outlook For Bio-Techne
01/31/2024 14:01:44

Bio-Techne Announced That Its Spatial Biol...
01/25/2024 12:11:07

. The multiomics application will be commercially available in Q2 2024.

Bio-Techne President, Diagnostics and Geno...
01/05/2024 12:11:27

Bio-Techne Corporation (NASDAQ:TECH) today announced Matthew F. McManus has been appointed President, Diagnostics and Genomics ...

Bio-Techne Announces Submission Of FDA Dru...
12/20/2023 12:06:43

Bio-Techne's Lunaphore And SIB Swiss Insti...
12/14/2023 12:22:17

Expert Ratings for Bio-Techne
12/07/2023 13:00:10

UBS Initiates Coverage On Bio-Techne with ...
12/07/2023 11:07:53

UBS analyst Dan Leonard initiates coverage on Bio-Techne (NASDAQ:TECH) with a Buy rating and announces Price Target of $80.